A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide ... practice rather than a fixed-dose protocol. Among the 750 enrolled ...

Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

The researchers found that after 64 weeks, participants had a mean weight loss of −16.7%, with a mean semaglutide dose of 1.08mg/week.

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

Perspective from Sangeeta Kashyap, MD Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight -- without causing nausea.

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

If tirzepatide can’t be accessed, semaglutide is still a good choice because 15% weight loss, particularly at the population level, is enormous. “Ten years ago, if someone had told you semaglutide was ...

Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that can assist with diabetes management and weight loss. Experts are interested in understanding additional ...

The hazard ratio (HR) of MACEs for patients receiving semaglutide was 0.63 (95% CI, 0.41-0.95) during the first 3 months. “The HRs for MACEs were below 1 before the weight loss started and ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...